These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 36934279

  • 1. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report.
    Zolfaghari Emameh R, Heshmatnia J.
    J Med Case Rep; 2023 Mar 19; 17(1):101. PubMed ID: 36934279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Venous thromboembolism and COVID-19: a case report and review of the literature.
    Bhatt H, Singh S.
    J Med Case Rep; 2020 Oct 15; 14(1):188. PubMed ID: 33054805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study.
    Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, van Eickels M, Gebel M, Zell E, Turpie AG.
    Lancet Haematol; 2016 Jan 15; 3(1):e12-21. PubMed ID: 26765643
    [Abstract] [Full Text] [Related]

  • 6. Acute pancreatitis complicated with deep vein thrombosis and pulmonary embolism: a case report.
    Herath HM, Kulatunga A.
    J Med Case Rep; 2016 Jun 23; 10(1):182. PubMed ID: 27339635
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Warfarin versus direct oral anticoagulants for patients needing distal deep vein thrombosis treatment.
    Pham A, Heib A, Goodman E, Cotto R, Jafari P, Lipsitz E, Indes J.
    J Vasc Surg Venous Lymphat Disord; 2022 Jul 23; 10(4):826-831.e1. PubMed ID: 35124243
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of oral anticoagulants for the extended treatment of venous thromboembolism using a mixed-treatment comparison, meta-analytic approach.
    Rollins BM, Silva MA, Donovan JL, Kanaan AO.
    Clin Ther; 2014 Oct 01; 36(10):1454-64.e3. PubMed ID: 25092394
    [Abstract] [Full Text] [Related]

  • 12. Deep vein thrombosis with pulmonary thromboembolism in a case of severe COVID-19 pneumonia.
    Devi S, Mohakud S, Kar N, Muthuvel D.
    BMJ Case Rep; 2021 Jan 15; 14(1):. PubMed ID: 33452066
    [Abstract] [Full Text] [Related]

  • 13. Shortened length of hospital stay with rivaroxaban in patients with symptomatic venous thromboembolism in Japan: the J-EINSTEIN pulmonary embolism and deep vein thrombosis program.
    Matsuo H, Prins M, Lensing AW, Fujinuma EW, Miyamoto Y, Kajikawa M.
    Curr Med Res Opin; 2015 Jun 15; 31(6):1057-61. PubMed ID: 25851062
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities.
    Prandoni P, Barbar S, Milan M, Vedovetto V, Pesavento R.
    Eur J Intern Med; 2014 Jan 15; 25(1):25-30. PubMed ID: 24120221
    [Abstract] [Full Text] [Related]

  • 16. Recurrent venous thromboembolism after discontinuation of rivaroxaban therapy in a patient with antiphospholipid syndrome.
    Yagi S, Nishiyama S, Abe T, Sata M.
    BMJ Case Rep; 2019 Jan 10; 12(1):. PubMed ID: 30635311
    [Abstract] [Full Text] [Related]

  • 17. Indirect comparison and cost-utility of dabigatran etexilate and rivaroxaban in the treatment and extended anticoagulation of venous thromboembolism in a UK setting.
    Jugrin AV, Hösel V, Ustyugova A, De Francesco M, Lamotte M, Sunderland T.
    J Med Econ; 2016 Jan 10; 19(1):1-10. PubMed ID: 26390231
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of rivaroxaban use in patients with gynecologic malignancies at an academic medical center: A pilot study.
    Signorelli JR, Gandhi AS.
    J Oncol Pharm Pract; 2019 Mar 10; 25(2):362-368. PubMed ID: 29157146
    [Abstract] [Full Text] [Related]

  • 19. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A, Desai A, Calixte R, Aparnath M, Hindenburg A, Salzman S, Mathew JP.
    Lung; 2016 Aug 10; 194(4):605-11. PubMed ID: 27192990
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.